EXPERIENCE IN THE USE OF MINERAL WATER «NAFTUSYA» OF ZBRUCHANSK FIELD IN THE TREATMENT OF PATIENTS WITH UROLITHS
- Authors: Konstantinova O.V1, Dutov V.V1, Katibov M.I1, Trapeznikova M.F1, Yanenko E.K1, Merinov D.S1
-
Affiliations:
- Issue: No 6 (2013)
- Pages: 9-13
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/280005
- ID: 280005
Cite item
Open Access
Access granted
Abstract
The study has evaluated the effect of combined treatment including slightly mineralized hydrocarbonate-magnesium-calcium mineral water «Naftusya» of Zbruchansk field on the urinary system of 47 adult patients with urolithiasis and chronic pyelonephritis aged 24 to 76 years and 3 children of different age groups. 14 patients dropped out of the study group after 1-3 days after the start of treatment due to the negative reaction of the gastrointestinal tract to the reception of water; thus, study group consisted of 36 patients. At baseline, kidney or ureteral stones were diagnosed in all patients. For adult patients, water was administered at a dose 200 ml 3 times a day, for children - 50-150 ml 3 times a day, 30-40 minutes before meals for 7-20 days. Examination of patients was performed using laboratory, ultrasound and radiographic methods. It was revealed that against the background of complex treatment, discharge of small stones, their fragments and urinary sand have occurred 1-3 days earlier than with standard treatment. There was no effect on calcium and inorganic phosphate metabolism. The trend to uric acid crystalluria and reducing the pH of urine was revealed. Statistically significant reduction of leukocyturia and erythrocyturia was identified. 60% of patients had a disappearance of bacteriuria or reduction of the titer of bacteria. The results led to the conclusion of advisability of use of mineral water «Naftusya» of Zbruchansk field in the complex treatment of inflammatory processes in the urinary system and for stimulation of discharge of ureteral stones with sizes enabaling to presume their independent discharge.
Full Text
About the authors
O. V Konstantinova
V. V Dutov
M. I Katibov
M. F Trapeznikova
E. K Yanenko
D. S Merinov
References
- Руководство по урологии в 3 т. Под ред. Н.А. Лопаткина. М., Медицина. 1998.
- Тиктинский О.Л., Александров В.П. Мочекаменная болезнь. СПб.: «Питер», 2000, C. 384.
- Assimos D.G. Nephrolithiasis in patients with urinary diversion. J. Urol. 1996; 155(1): 69-70.
- Nelson W.K., Houghton S.G., Milliner D.S. et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 2005; 1(5): 481-485.
- Аполихин О.И., Сивков А.В., Бешлиев Д.А. и др. Анализ уронефрологической заболеваемости в Российской Федерации по данным официальной статистики. Экспериментальная и клиническая урология. 2010; 1: 4-11.
- Tiselius H.-G. Epidemiology and medical management of stone disease. BJU Int. 200; 91: 758-767.
- Morse R.M., Resnik M.I. Ureteral calculi: Natural history and treatment in era of advanced technology. J. Urol. 1991; 145: 263.
- Porpiglia F., Destefanis P., Fiori C. et al. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology. 2000; 56: 579-583.
- Porpiglia F., Vaccino D., Billia M. et al. Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur. Urol. 2006; 50(2): 339-344.
- Аляев Ю.Г., Амосов А.В., Григорян В.А. и соавт. Возможности применения канефрона Н для лечения и профилактики мочекаменной болезни. Русский медицинский журнал. 2007; 15(13): 1—4.
- Колпаков И.С. Мочекаменная болезнь. Пособие для врачей. М., 2006. 21 с.
- Borghi L., Meschi T., Schianchi T. et al. Urine volume stone risk factor and preventive measure. Nephron. 1999; 81(3): 31-37.
- Breslau N., Brinkley L., Hill K. et al. Relationship of animal proteinrich diet to kidney stone formation. J. Clin. Endocrinol. Metab. 1988; 66(5): 140-146.
- Яненко Э.К., Константинова О.В., Чудновская М.В. и др. Диспансеризация больных кальций-фосфатным уролитиазом. Сб. трудов: Амбулаторная урология. М., 1994. C. 89-94.
- Большая медицинская энциклопедия. М.: «Медицинская энциклопедия», 1960. Т. 18. С. 600-615.
- Нестеров Н.И., Дзеранов Н.К., Ли А.А. и др. Применение физических и бальнеологических факторов в медицинской реабилитации больных мочекаменной болезнью, леченных дистанционной литотрипсией: Пособие для врачей. М., 1999. 20 c.
- Гублер Е.В. Вычислительные методы анализа и распознавания патологических процессов. М., «Медицина», 1978. С. 296.
- Гапоненко А.Д., Доста Н.И., Ниткин Д.М. и др. Возможности применения препарата Уролесан в лечении заболеваний мочевой системы. Медицинские новости. 2012; 4: 61-64.
- Gravas S., Tzortzis V., Karatzas A. The use of tamsulosin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res. 2007; 35: 231-235.
Supplementary files
